NAD+ and GHK-Cu peptides: what TikTok gets right and wrong

What's this video probably claiming?

Based on the caption framing and the medspa context, this video almost certainly positions NAD+ and GHK-Cu as complementary tools, one for systemic cellular energy and longevity, the other for skin repair and collagen synthesis. The creator likely suggests that the two serve different biological roles and that some people might benefit from using both. Phrases like "different jobs, different results" point toward a comparison framework: NAD+ precursors for mitochondrial function and DNA repair, GHK-Cu for tissue remodeling and wound healing signaling. This is a reasonable framing, but medspa TikTok accounts have a reliable tendency to overstate the translation from bench research to clinical outcomes. The hashtag "medspalife" signals a commercial context, which matters when evaluating how aggressively the evidence gets massaged.

What does the science actually show?

GHK-Cu (copper peptide GHK-Cu) does have a reasonably interesting body of preclinical work. Pickart et al. (2015, Cosmetics) documented its role in stimulating collagen and glycosaminoglycan synthesis in fibroblast models, and some small human trials on topical formulations show measurable improvements in skin density and wrinkle depth. The problem is that most injectable or systemic GHK-Cu data remains in cell cultures and animal models. NAD+ precursors, specifically NMN and NR, have more human trial data. Yoshino et al. (2021, Science) found 250mg/day NMN improved muscle insulin sensitivity in postmenopausal women, though the effect size was modest. Remie et al. (2020, Cell Metabolism) showed NR at 1000mg/day raised blood NAD+ by roughly 60% but produced no significant metabolic changes in healthy overweight adults. The gap between "NAD+ goes up" and "you feel or look better" is real and currently underappreciated on social media.

Where does the social media noise diverge from clinical reality?

The core problem with comparison videos like this one is the implied dose-response certainty. Medspa creators speak about these compounds as if the clinical evidence for injectable or oral NAD+ precursors and systemic GHK-Cu directly mirrors the cosmetic marketing copy. It does not. Topical GHK-Cu at concentrations between 1-5% has legitimate dermatology support. Systemic GHK-Cu administered via injection sits in a much thinner evidence zone, with no large randomized controlled trials in humans establishing safety profiles or effective doses for anti-aging purposes. The "your body might need one or both" framing is the part that concerns me most. It nudges viewers toward self-selecting peptide stacks without acknowledging that GHK-Cu's systemic effects on growth factor signaling, including TGF-beta and VEGF pathways documented by Pickart and Margolina (2018, Biomolecules), have not been tested for long-term safety in healthy humans outside of wound-healing clinical contexts.

What should you actually know?

Both compounds are genuinely interesting scientifically. Neither has enough human clinical trial data to support the confident, results-oriented framing that medspa TikTok routinely applies to them. GHK-Cu topically applied is the version with the most credible cosmetic evidence. NAD+ precursor supplementation raises circulating NAD+ levels in humans, but whether that translates to meaningful anti-aging outcomes in healthy adults remains genuinely unresolved. A 2023 review by Mehmel et al. in Nutrients noted the heterogeneity of NAD+ trial results and called for larger, longer studies before clinical recommendations can be made confidently. If you are considering either compound beyond a basic topical skincare product, that conversation belongs with a licensed clinician reviewing your specific labs and history, not a TikTok comment section. The "one size fits all" rejection the creator offers is accurate. The implied certainty about which size fits you is not.